報價延遲最少15分鐘:2025/06/05 19:18 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
22.45 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.14/-5.25
|
|
企業價值
423.64M
|
| 資產負債 |
|
每股賬面淨值
16.12
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/05 19:18 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis. |